0001615774-15-001407.txt : 20150608 0001615774-15-001407.hdr.sgml : 20150608 20150608171922 ACCESSION NUMBER: 0001615774-15-001407 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150604 FILED AS OF DATE: 20150608 DATE AS OF CHANGE: 20150608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001266806 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 BUSINESS PHONE: 818-833-5000 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ripley Anne-Marie Juliette CENTRAL INDEX KEY: 0001625186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36747 FILM NUMBER: 15919166 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 4 1 s101281_form4.xml 4 X0306 4 2015-06-04 0 0001266806 SECOND SIGHT MEDICAL PRODUCTS INC EYES 0001625186 Ripley Anne-Marie Juliette 12744 SAN FERNANDO ROAD, BLDG. 3 SYLMAR CA 91342 0 1 0 0 VP Regulatory Affairs COMMON STOCK 2015-06-04 4 M 0 4371 4.75 A 4371 D COMMON STOCK 2015-06-04 4 S 0 4371 15.00 D 0 D Option 4.75 2015-06-04 4 M 0 4371 0 D 2015-09-01 Common Stock 4371 0 D Option 4.75 2016-01-01 Common Stock 2500 2500 D Option 5.00 2017-01-01 Common Stock 6125 6125 D Option 5.00 2018-04-01 Common Stock 4750 4750 D Option 5.00 2018-11-01 Common Stock 25000 25000 D Option 5.00 2019-02-01 Common Stock 6750 6750 D Option 5.00 2020-02-01 Common Stock 10125 10125 D Option 5.00 2020-02-01 Common Stock 10625 10625 D Option 5.00 2021-03-01 Common Stock 8313 8313 D Option 5.00 2022-03-01 Common Stock 5813 5813 D Option 5.00 2024-04-01 Common Stock 3125 3125 D Ms. Ripley exercised 4,371 vested options (which expire on September 1, 2015) reported as Option(1) on Form 3 filed with the SEC on November 18, 2014. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter and as further disclosed in the Company's prospectus dated November 20, 2014. These are vested employee options currently exercisable. Excludes employee options, covering 89,781 shares, not exercisable for over 60 days from this date. Sales reported in this Form 4 constitute the final trades contemplated upon expiration of the six month lock-up noted in footnote 2 above, with the Reporting Person's share sales after this date remaining subject to a 12 month lock-up that commenced from the IPO date. /s/ Anne-Marie Ripley 2015-06-08